Inventor
CREN SYLVAINE
CH15 patents
⚠️ This page may combine multiple inventors who share the name “CREN SYLVAINE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BUR DANIEL
8 patentsUS8288419B2Oct 16, 2012
Aminopyrazole derivatives
BUR DANIEL7 citations80
US8846733B2Sep 30, 2014
Oxazolyl-methylether derivatives as ALX receptor agonists
BUR DANIEL4 citations71
US8563714B2Oct 22, 2013
Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists
BUR DANIEL4 citations61
US8536209B2Sep 17, 2013
Aminotriazole derivatives as ALX agonists
BUR DANIEL2 citations61
US9346793B2May 24, 2016
Hydroxylated aminotriazole derivatives as ALX receptor agonists
BUR DANIEL1 citations51
US8674111B2Mar 18, 2014
Oxazole and thiazole derivatives as ALX receptor agonists
BUR DANIEL1 citations51
US8580831B2Nov 12, 2013
Fluorinated aminotriazole derivatives
BUR DANIEL1 citations51
US9187435B2Nov 17, 2015
Bridged Spiro[2.4]heptane ester derivatives
BUR DANIEL1 citations50
ACTELION PHARMACEUTICALS LTD
5 patentsUS9284288B2Mar 15, 2016
1-(p-tolyl) cyclopropyl substituted bridged spiro[2.4]heptane derivatives as ALX receptor agonists
ACTELION PHARMACEUTICALS LTD2 citations61
US9663473B2May 30, 2017
Benzimidazolyl-methyl urea derivatives as ALX receptor agonists
ACTELION PHARMACEUTICALS LTD1 citations51
US9676761B2Jun 13, 2017
Difluoroethyl-oxazole substituted bridged spiro[2.4]heptane derivatives as ALX receptor agonists
ACTELION PHARMACEUTICALS LTD0 citations50
US9533964B2Jan 3, 2017
Piperazine substituted bridged spiro[2.4]heptane derivatives as ALX receptor agonists
ACTELION PHARMACEUTICALS LTD0 citations50
US9527867B2Dec 27, 2016
Antibacterial biaromatic derivatives
ACTELION PHARMACEUTICALS LTD1 citations49